BriaCell Therapeutics Corp. (BCTX, BCTXL, BCTXZ) (CIK 0001610820) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001493152-26-000533
- Form
- CORRESP
- Filer
- BriaCell Therapeutics Corp. (BCTX, BCTXL, BCTXZ) (CIK 0001610820)
- CIK
- 0001610820
- Ticker
- BCTX, BCTXL, BCTXZ
- Filed
- 2026-01-06
- SIC industry
- 2834
- HQ
- West Vancouver, A1
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1610820/000149315226000533/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer